23h
Basingstoke Gazette on MSNNew initiative to improve chronic kidney disease screeningThe new initiative aims to improve early detection by increasing access to screening in communities where accessing care is more difficult.
The table is a review of notable updates that occurred in February 2025 for investigational products in development.
A rise in the use of non-FDA-approved diabetes and obesity medications has spurred health care professionals and medical ...
DelveInsight's "VITRAKVI Market Size, Forecast, and Market Insight Report" highlights the details around VITRAKVI, a TRK, ...
VITRAKVI has strong market potential as a first-in-class TRK inhibitor for patients with NTRK gene fusion-positive cancers, regardless of tumor type. The growing adoption of precision oncology ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results